| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $238.75K | $939.92K | $3.54M | $434.43K | $495.54K |
| R&D | – | – | – | – | – |
| SG&A | $238.75K | $880.95K | $665.28K | $744.43K | $495.54K |
| Operating Income | -$238.75K | -$927.92K | -$3.53M | -$422.43K | -$495.54K |
| Interest Expense | $36.00K | – | $99.02K | $11.02K | $6.83K |
| Tax Expense | – | – | – | – | – |
| Net Income | $2.38M | -$3.23M | -$4.19M | -$765.73K | -$1.35M |
| EPS (basic) | 0.0500 | -0.0700 | -0.0900 | -0.0200 | -0.0300 |
| EPS (diluted) | 0.0500 | -0.0700 | -0.0900 | -0.0200 | – |
| Shares (diluted) | $47.80M | $46.88M | $46.88M | $46.88M | $44.26M |